• Most Popular
  • Most Shared

US FDA objects to TV ad for Rozerem sleep drug

Thu Mar 8, 2007 1:26pm EST

Stocks

   

Regulatory News

WASHINGTON, March 8 (Reuters) - A Takeda Pharmaceutical Co. (4502.T) television commercial for insomnia drug Rozerem should have included information about its risks, U.S. regulators said in a letter released on Thursday.

The Food and Drug Administration said the 10-second ad "was not an appropriate reminder ad." Reminder ads, which typically only mention a drug's name, do not need to balance benefit and risk information.

((Reporting by Lisa Richwine, editing by J.S. Benkoe; Reuters Messaging: lisa.richwine.reuters.com@reuters.net; +1 202 310-5691)) Keywords: TAKEDA AD/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWBT006655
Regulatory News


More from Reuters

Photo

U.S.-led climate deal under threat in Copenhagen

COPENHAGEN (Reuters) - U.N. climate talks fell into crisis on Saturday after some developing nations angrily rejected a plan worked out by U.S. President Barack Obama and leaders of other major economies for fighting global warming. | Video

» More Top News
A woman shops at a Sam's Club store, a division of Wal-Mart Stores, in Bentonville, Arkansas June 4, 2009. REUTERS/Jessica Rinaldi

The food-stamp economy

On the last day of every month, shoppers at Walmart load their carts with food and household items and wait for the midnight hour. Is this the new normal in America?  Full Article 

U.S.
Two men shake hands in a file photo. REUTERS/File

Let's make a deal

The battered M&A sector will make a tepid recovery in the coming year and three hot sectors will lead the way, according to a Thomson Reuters analysis.  Full Article 

Global Deals Review